INSTIL BIO INC's ticker is TIL and the CUSIP is 45783C101. A total of 78 filers reported holding INSTIL BIO INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $37,127,000 | +4.8% | 7,670,793 | 0.0% | 0.79% | -16.2% |
| Q2 2022 | $35,439,000 | -32.3% | 7,670,793 | +57.5% | 0.94% | -17.3% |
| Q1 2022 | $52,361,000 | -37.2% | 4,870,793 | 0.0% | 1.14% | -22.3% |
| Q4 2021 | $83,339,000 | -4.3% | 4,870,793 | 0.0% | 1.47% | +21.8% |
| Q3 2021 | $87,065,000 | -7.5% | 4,870,793 | 0.0% | 1.21% | -20.1% |
| Q2 2021 | $94,104,000 | -23.0% | 4,870,793 | 0.0% | 1.51% | -18.0% |
| Q1 2021 | $122,159,000 | – | 4,870,793 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Curative Ventures V LLC | 37,980,073 | $649,839,000 | 100.00% |
| CPMG Inc | 8,478,790 | $145,072,000 | 26.75% |
| VR Adviser, LLC | 6,865,076 | $117,461,000 | 16.06% |
| Vivo Capital, LLC | 12,486,787 | $213,649,000 | 12.88% |
| Samsara BioCapital, LLC | 1,991,950 | $34,082,000 | 6.61% |
| Fairmount Funds Management LLC | 673,905 | $11,531,000 | 3.80% |
| RA Capital Management | 4,870,793 | $83,339,000 | 1.47% |
| Parametrica Management Ltd | 50,699 | $867,000 | 0.86% |
| HighVista Strategies LLC | 56,901 | $974,000 | 0.78% |
| Nicholas Investment Partners, LP | 713,221 | $12,203,000 | 0.77% |